Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Novo Nordisk and Eli Lilly have used submissions to the federal government’s budget process to argue reducing obesity will be ...

Ascendis Pharma AS (ASND) reports significant milestones and market traction, despite facing revenue and reimbursement hurdles.

US President Donald Trump signed a Presidential memo on reciprocal tariffs to order his administration to investigate the ...

Explore the science behind why we always have room for dessert, even after a full meal, and the brain's sugar cravings.

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

Novo Nordisk has reached an agreement to buy Germany’s Cardior Pharmaceuticals for €1.025 billion ($1.1 billion), adding expertise in RNA therapeutics and a heart failure therapy in mid-stage ...

COPENHAGEN--Novo Nordisk will launch its hugely popular ... The company has so far only launched Wegovy in the U.S., Britain, Germany, Norway, and its home market Denmark. Wegovy is the first ...

Having struck investment deals with big UAE names such as IHC, Aldar and ADNOC Gas, he is scouting for more deals in the ...